{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:40:05Z","timestamp":1792795205172,"version":"4.5.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170089"],"award-info":[{"award-number":["82170089"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["PWRd2020-06"],"award-info":[{"award-number":["PWRd2020-06"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82202401"],"award-info":[{"award-number":["82202401"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Advanced Research"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.jare.2025.07.017","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T20:10:07Z","timestamp":1752610207000},"page":"881-900","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Hyodeoxycholic acid relieves neuropathic pain by activating farnesoid X receptor signaling"],"prefix":"10.1016","volume":"82","author":[{"given":"Jiaqi","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejiao","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zehua","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongze","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuwen","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianhao","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6999-6833","authenticated-orcid":false,"given":"Wenying","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zetian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunzheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changshun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3698-5636","authenticated-orcid":false,"given":"Lijun","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jare.2025.07.017_b0005","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41572-023-00484-9","article-title":"Central neuropathic pain","volume":"9","author":"Rosner","year":"2023","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"10.1016\/j.jare.2025.07.017_b0010","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1152\/physrev.00045.2019","article-title":"Neuropathic pain: from mechanisms to treatment","volume":"101","author":"Finnerup","year":"2021","journal-title":"Physiol Rev"},{"issue":"10289","key":"10.1016\/j.jare.2025.07.017_b0015","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1016\/S0140-6736(21)00392-5","article-title":"Nociplastic pain: towards an understanding of prevalent pain conditions","volume":"397","author":"Fitzcharles","year":"2021","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.jare.2025.07.017_b0020","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1111\/cns.14154","article-title":"Activation of the bile acid receptors TGR5 and FXR in the spinal dorsal horn alleviates neuropathic pain","volume":"29","author":"Wu","year":"2023","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.jare.2025.07.017_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107361","article-title":"Gut microbiota-brain bile acid axis orchestrates aging-related neuroinflammation and behavior impairment in mice","volume":"208","author":"Ma","year":"2024","journal-title":"Pharmacol Res"},{"issue":"11","key":"10.1016\/j.jare.2025.07.017_b0030","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s40265-023-01903-7","article-title":"Neuropathic pain and spinal cord injury: management, phenotypes, and biomarkers","volume":"83","author":"Widerstrom-Noga","year":"2023","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.jare.2025.07.017_b0035","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/j.pain.0000000000001365","article-title":"The IASP classification of chronic pain for ICD-11: chronic neuropathic pain","volume":"160","author":"Scholz","year":"2019","journal-title":"Pain"},{"key":"10.1016\/j.jare.2025.07.017_b0040","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1146\/annurev-pharmtox-010818-021524","article-title":"Neuropathic pain: mechanism-based therapeutics","volume":"60","author":"Bannister","year":"2020","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"1","key":"10.1016\/j.jare.2025.07.017_b0045","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41582-022-00741-7","article-title":"Maximizing treatment efficacy through patient stratification in neuropathic pain trials","volume":"19","author":"Baron","year":"2023","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.jare.2025.07.017_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112610","article-title":"Therapeutic promise of carotenoids as antioxidants and anti-inflammatory agents in neurodegenerative disorders","volume":"146","author":"Kabir","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jare.2025.07.017_b0055","doi-asserted-by":"crossref","first-page":"478","DOI":"10.3389\/fnins.2020.00478","article-title":"Exploring the promise of flavonoids to combat neuropathic pain: from molecular mechanisms to therapeutic implications","volume":"14","author":"Uddin","year":"2020","journal-title":"Front Neurosci"},{"issue":"7","key":"10.1016\/j.jare.2025.07.017_b0060","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1080\/13543776.2024.2314296","article-title":"Patented farnesoid X receptor modulators: a review (2019 - present)","volume":"34","author":"Gioiello","year":"2024","journal-title":"Expert Opin Ther Pat"},{"issue":"1","key":"10.1016\/j.jare.2025.07.017_b0065","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/s41392-023-01673-4","article-title":"Gut liver brain axis in diseases: the implications for therapeutic interventions","volume":"8","author":"Yan","year":"2023","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"10.1016\/j.jare.2025.07.017_b0070","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.cmet.2017.03.007","article-title":"Farnesoid X receptor regulation of the NLRP3 inflammasome underlies cholestasis-associated sepsis","volume":"25","author":"Hao","year":"2017","journal-title":"Cell Metab"},{"key":"10.1016\/j.jare.2025.07.017_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102719","article-title":"Fibroblast growth factor 19 modulates intestinal microbiota and inflammation in presence of farnesoid X receptor","volume":"54","author":"Gadaleta","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jare.2025.07.017_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108238","article-title":"Bile acid metabolism and signaling, the microbiota, and metabolic disease","volume":"237","author":"Cai","year":"2022","journal-title":"Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.jare.2025.07.017_b0085","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41392-024-01811-6","article-title":"Bile acid metabolism and signaling in health and disease: molecular mechanisms and therapeutic targets","volume":"9","author":"Fleishman","year":"2024","journal-title":"Signal Transduct Target Ther"},{"issue":"11","key":"10.1016\/j.jare.2025.07.017_b0090","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.4103\/1673-5374.259617","article-title":"Hyodeoxycholic acid protects the neurovascular unit against oxygen-glucose deprivation and reoxygenation-induced injury in vitro","volume":"14","author":"Li","year":"2019","journal-title":"Neural Regen Res"},{"issue":"1","key":"10.1016\/j.jare.2025.07.017_b0095","doi-asserted-by":"crossref","first-page":"5451","DOI":"10.1038\/s41467-023-41061-8","article-title":"Hyodeoxycholic acid ameliorates nonalcoholic fatty liver disease by inhibiting RAN-mediated PPARalpha nucleus-cytoplasm shuttling","volume":"14","author":"Zhong","year":"2023","journal-title":"Nat Commun"},{"issue":"7","key":"10.1016\/j.jare.2025.07.017_b0100","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1177\/02698811221089041","article-title":"Hyodeoxycholic acid inhibits lipopolysaccharide-induced microglia inflammatory responses through regulating TGR5\/AKT\/NF-kappaB signaling pathway","volume":"36","author":"Zhu","year":"2022","journal-title":"J Psychopharmacol"},{"issue":"2","key":"10.1016\/j.jare.2025.07.017_b0105","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0304-3959(00)00276-1","article-title":"Spared nerve injury: an animal model of persistent peripheral neuropathic pain","volume":"87","author":"Decosterd","year":"2000","journal-title":"Pain"},{"key":"10.1016\/j.jare.2025.07.017_b0110","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20210920","article-title":"ZNF382 controls mouse neuropathic pain via silencer-based epigenetic inhibition of Cxcl13 in DRG neurons","volume":"218","author":"Ma","year":"2021","journal-title":"J Exp Med"},{"key":"10.1016\/j.jare.2025.07.017_b0115","article-title":"Dimethyl itaconate attenuates CFA-Induced inflammatory pain via the NLRP3\/ IL-1beta signaling pathway","volume":"13","author":"Lin","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jare.2025.07.017_b0120","doi-asserted-by":"crossref","DOI":"10.1136\/rapm-2024-106195","article-title":"Elevated 18:1 lysophosphatidylcholine contributes to neuropathic pain in peripheral nerve injury","author":"Ren","year":"2025","journal-title":"Reg Anesth Pain Med"},{"issue":"13","key":"10.1016\/j.jare.2025.07.017_b0125","article-title":"Downregulation of a dorsal root ganglion-specifically enriched long noncoding RNA is required for neuropathic pain by negatively regulating RALY-triggered Ehmt2 expression","volume":"8","author":"Pan","year":"2021","journal-title":"Adv Sci (Weinh)"},{"issue":"4","key":"10.1016\/j.jare.2025.07.017_b0130","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.ymthe.2023.01.018","article-title":"Gut microbial metabolite hyodeoxycholic acid targets the TLR4\/MD2 complex to attenuate inflammation and protect against sepsis","volume":"31","author":"Li","year":"2023","journal-title":"Mol Ther"},{"issue":"8","key":"10.1016\/j.jare.2025.07.017_b0135","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202250299","article-title":"Bile acid-activated receptors in innate and adaptive immunity: targeted drugs and biological agents","volume":"53","author":"Cheung","year":"2023","journal-title":"Eur J Immunol"},{"issue":"6","key":"10.1016\/j.jare.2025.07.017_b0140","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1124\/pharmrev.124.000978","article-title":"Bile acid signaling in metabolic and inflammatory diseases and drug development","volume":"76","author":"Li","year":"2024","journal-title":"Pharmacol Rev"},{"issue":"2","key":"10.1016\/j.jare.2025.07.017_b0145","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1096\/fj.201800935RR","article-title":"Bile acids induce visceral hypersensitivity via mucosal mast cell-to-nociceptor signaling that involves the farnesoid X receptor\/nerve growth factor\/transient receptor potential vanilloid 1 axis","volume":"33","author":"Li","year":"2019","journal-title":"FASEB J"},{"issue":"3","key":"10.1016\/j.jare.2025.07.017_b0150","first-page":"879","article-title":"Bile acids promote gastric intestinal metaplasia by upregulating CDX2 and MUC2 expression via the FXR\/NF-kappaB signalling pathway","volume":"54","author":"Yu","year":"2019","journal-title":"Int J Oncol"},{"issue":"6","key":"10.1016\/j.jare.2025.07.017_b0155","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.jhep.2019.06.017","article-title":"FXR modulates the gut-vascular barrier by regulating the entry sites for bacterial translocation in experimental cirrhosis","volume":"71","author":"Sorribas","year":"2019","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.jare.2025.07.017_b0160","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/j.apsb.2021.12.011","article-title":"Bile acid coordinates microbiota homeostasis and systemic immunometabolism in cardiometabolic diseases","volume":"12","author":"Guan","year":"2022","journal-title":"Acta Pharm Sin B"},{"issue":"12","key":"10.1016\/j.jare.2025.07.017_b0165","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1038\/s41591-018-0222-4","article-title":"Gut microbiota and intestinal FXR mediate the clinical benefits of metformin","volume":"24","author":"Sun","year":"2018","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.jare.2025.07.017_b0170","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nrgastro.2017.119","article-title":"Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis","volume":"15","author":"Jia","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.jare.2025.07.017_b0175","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/s40168-023-01709-5","article-title":"Gut microbiota-bile acid crosstalk regulates murine lipid metabolism via the intestinal FXR-FGF19 axis in diet-induced humanized dyslipidemia","volume":"11","author":"Xu","year":"2023","journal-title":"Microbiome"},{"issue":"4","key":"10.1016\/j.jare.2025.07.017_b0180","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1002\/hep.32608","article-title":"Probiotic-derived nanoparticles inhibit ALD through intestinal miR194 suppression and subsequent FXR activation","volume":"77","author":"Jiang","year":"2023","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.jare.2025.07.017_b0185","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41579-022-00805-x","article-title":"Bile acids and the gut microbiota: metabolic interactions and impacts on disease","volume":"21","author":"Collins","year":"2023","journal-title":"Nat Rev Microbiol"},{"issue":"3","key":"10.1016\/j.jare.2025.07.017_b0190","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1124\/pharmrev.121.000349","article-title":"Matrix metalloproteinases: from molecular mechanisms to physiology, pathophysiology, and pharmacology","volume":"74","author":"de Almeida","year":"2022","journal-title":"Pharmacol Rev"},{"issue":"1","key":"10.1016\/j.jare.2025.07.017_b0195","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s12974-023-02841-7","article-title":"Elevated blood and cerebrospinal fluid biomarkers of microglial activation and blood\u2013brain barrier disruption in anti-NMDA receptor encephalitis","volume":"20","author":"Chang","year":"2023","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.jare.2025.07.017_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.116786","article-title":"The role of matrix metalloproteinases in osteoarthritis pathogenesis: an updated review","volume":"234","author":"Mehana","year":"2019","journal-title":"Life Sci"},{"issue":"Pt 1","key":"10.1016\/j.jare.2025.07.017_b0205","article-title":"Matrix metalloproteinases as attractive therapeutic targets for chronic pain: a narrative review","volume":"261","author":"Dai","year":"2024","journal-title":"Int J Biol Macromol"},{"issue":"Pt 3","key":"10.1016\/j.jare.2025.07.017_b0210","article-title":"Biological significance and pathophysiological role of matrix metalloproteinases in the central nervous system","volume":"280","author":"Ganguly","year":"2024","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.jare.2025.07.017_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2024.103214","article-title":"PPARG-mediated autophagy activation alleviates inflammation in rheumatoid arthritis","volume":"146","author":"Geng","year":"2024","journal-title":"J Autoimmun"},{"issue":"7","key":"10.1016\/j.jare.2025.07.017_b0220","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1111\/bph.16244","article-title":"A partial agonist of PPARgamma prevents paclitaxel-induced peripheral neuropathy in mice, by inhibiting neuroinflammation","volume":"181","author":"Benvenutti","year":"2024","journal-title":"Br J Pharmacol"}],"container-title":["Journal of Advanced Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123225005430?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123225005430?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T08:14:45Z","timestamp":1777623285000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2090123225005430"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":44,"alternative-id":["S2090123225005430"],"URL":"https:\/\/doi.org\/10.1016\/j.jare.2025.07.017","relation":{},"ISSN":["2090-1232"],"issn-type":[{"value":"2090-1232","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyodeoxycholic acid relieves neuropathic pain by activating farnesoid X receptor signaling","name":"articletitle","label":"Article Title"},{"value":"Journal of Advanced Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jare.2025.07.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of Cairo University.","name":"copyright","label":"Copyright"}]}}